BRIEF published on 02/26/2025 at 15:06, 1 year 6 months ago Vanguard Group's Disclosure on Direct Line Insurance Stake Takeover Code Vanguard Group Securities Transactions Interest Disclosure Direct Line Insurance
BRIEF published on 02/26/2025 at 15:06, 1 year 6 months ago Divulgation par le groupe Vanguard de sa participation dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Opérations Sur Titres Divulgation Des Intérêts Assurance Ligne Directe
PRESS RELEASE published on 02/26/2025 at 15:01, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.39% ownership in Direct Line Insurance Group plc. Details of securities dealings included Securities Dealings The Vanguard Group Ownership Disclosure Financial Disclosure Direct Line Insurance Group Plc
BRIEF published on 02/25/2025 at 15:16, 1 year 6 months ago Vanguard Group Discloses Stake in Direct Line Insurance Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance Trading Activity
BRIEF published on 02/25/2025 at 15:16, 1 year 6 months ago Le groupe Vanguard dévoile sa participation dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Activité Commerciale Assurance Ligne Directe
PRESS RELEASE published on 02/25/2025 at 15:11, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.41% stake in Direct Line Insurance Group plc via Form 8.3. Disclosures also involve Aviva plc. Transactions include purchase and sale of ordinary securities Form 8.3 Vanguard Group Financial Disclosure Stock Transactions Direct Line Insurance
BRIEF published on 02/20/2025 at 15:21, 1 year 6 months ago Vanguard Discloses Position in Direct Line Insurance Disclosure Takeover Code Vanguard Group Share Transactions Direct Line Insurance
BRIEF published on 02/20/2025 at 15:21, 1 year 6 months ago Vanguard dévoile sa position dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Transactions Sur Actions Assurance Ligne Directe
PRESS RELEASE published on 02/20/2025 at 15:16, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.41% ownership in Direct Line Insurance Group plc. Additional 1% rule disclosures included Securities Disclosure Vanguard Group Ownership Direct Line Insurance
BRIEF published on 02/19/2025 at 15:33, 1 year 6 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Disclosure Takeover Code Vanguard Group Shareholding Direct Line
Published on 09/11/2026 at 04:00, 7 hours 23 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 58 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 3 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 23 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 8 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 3 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 18 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 23 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 53 minutes ago Availability of the 2026 Interim Financial Report
